C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
11/2002
11/07/2002	US20020165251 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder
11/07/2002	US20020165236 Such as 3-(3-(4-(4-sulfamoyl-benzylsulfamoyl-phenyl)-ureido)-benzamidine for treatment of malaria
11/07/2002	US20020165234 Selective B3 adrenergic agonists
11/07/2002	US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002	US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002	US20020165218 Mixture of kinase inhibitor and anticancer agents
11/07/2002	US20020164577 Detection of transmembrane potentials by optical methods
11/07/2002	US20020164549 Tellurium chemical sensitizers added to the photothermographic emulsion, for example tellurium complexed with four imidazolidin-2-thione groups and two chlorine atoms
11/07/2002	CA2408369A1 Substituted indoles as parp inhibitors
11/06/2002	EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
11/06/2002	EP1254885A1 Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups
11/06/2002	EP1254133A2 Indol-3-yl derivatives
11/06/2002	EP1254115A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
11/06/2002	EP1254114A2 Melanocortin receptor agonists and antagonists
11/06/2002	EP1254104A1 Quaternary ammonium compounds and their use as anti-tussive agent
11/06/2002	EP1030843A4 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
11/06/2002	EP0901373B1 Alpha v Beta 3 ANTAGONISTS
11/06/2002	CN1378542A FAB I inhibitors
11/06/2002	CN1378540A New piperazine and piperidine compounds
11/06/2002	CN1378533A Phenoxypropylamine compounds
11/06/2002	CN1378447A Use of cell membrane penetrating indigoid bisindole derivatives
11/06/2002	CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/06/2002	CN1093859C Novel indole-2,3-dione-3-oxime derivatives
11/06/2002	CN1093768C Diagnostic marker
11/06/2002	CN1093760C Use of carbazole compounds for treating congenstive heart failure medicine
11/05/2002	US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/05/2002	US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
11/05/2002	US6476063 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/05/2002	US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
11/05/2002	US6476053 Mycobacterial inhibitors
11/05/2002	US6476045 Indole and azaindole derivatives and their use as tachykinin antagonists, and in particular as neurokinin-1 receptor antagonist
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
11/05/2002	CA2038379C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
10/2002
10/31/2002	WO2002086078A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
10/31/2002	WO2002085883A1 Tricyclic alkylhydroxamates, their preparation and their use as cell proliferation inhibitors
10/31/2002	WO2002085856A1 Synthesis and methods of use of tetrahydroindolone analogues and derivatives
10/31/2002	WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002	WO2002085854A1 5-aryl-1.3.3.-trimethyl-2-methylene-indoline derivatives and salts thereof, methods for the production and use of said compounds for the temporary coloration of fibres
10/31/2002	WO2002085850A1 Cyclic amidine derivative
10/31/2002	WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002	WO2002085833A1 Processes for preparation of optically active 2-benzyl- succinic acid and optically active 2-benzylsuccinic acid monoamides
10/31/2002	WO2002085357A1 Nociceptin analogs
10/31/2002	WO2002085301A2 Indole, azaindole and related heterocyclic amidopiperazine derivatives
10/31/2002	WO2002068390A8 Diamides which inhibit tryptase and factor xa activity
10/31/2002	WO2002059089A3 Process for the preparation of heterocyclic indene analogs
10/31/2002	WO2002044416A3 Sulfonated diarylrhodamine dyes as fluorescent labels
10/31/2002	WO2002042412A3 Protease inhibitors and their pharmaceutical uses
10/31/2002	WO2002026720A3 PIPERAZINE BASED INHIBITORS OF FACTOR Xa
10/31/2002	WO2001070675A3 Inhibitors of histone deacetylase
10/31/2002	US20020161252 Zinc complex with a chiral ligand, such as diethylzinc((S,S)-N-N'-ethylene-bis-(1-phenylethylamine))
10/31/2002	US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002	US20020161236 2-methyl-3-(protected hydroxy) benzyl chloride; use making nelfinavir mesylate
10/31/2002	US20020161231 Intermediate for preparing camptothecin derivatives
10/31/2002	US20020161227 By reacting a phosphazenium compound with Q as counteranion with a halogenated aromatic compound to substitute at least one halogen atom with Q
10/31/2002	US20020161030 Sulpur derivatives containing a retroamide bond as inhibitors of endothelin-converting enzymes
10/31/2002	US20020161025 N-substituted indole-3glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action
10/31/2002	US20020161024 Administering 2-(piperidin-2,6-dion-3-yl),4-amino-isoindolin-1-one to treat an eye condition
10/31/2002	US20020160962 Non-structural protein 3 (NS3), part of a hepatitis C virus protease necessary for polypeptide processing and viral replication; alpha-ketoamide compounds of given formula
10/31/2002	US20020159973 Administering to the patient at least one statin (HMG-Coa-reductase inhibitor) in an amount effective to modulate MHC class II (Major Histocompability complex) or CD/40(antigen) expression in the patient
10/31/2002	CA2442994A1 Tricyclic alkylhydroxamates, their preparation and their use as cell proliferation inhibitors
10/30/2002	EP1253141A1 Substituted carbazoles as tubulin polymerization inhibitors and their use for the treatment of cancer
10/30/2002	EP1252803A1 Complexes of form l 2?mx as phosphorescent dopants for organic leds
10/30/2002	EP1252166A1 Olefin polymerization cocatalysts derived from group-15 cationic compounds and processes using them
10/30/2002	EP1252142A1 Indole derivatives as mcp-1 receptor antagonists
10/30/2002	EP1251862A1 Ophthalmic compositions for treating ocular hypertension
10/30/2002	EP1251839A2 Use of cox-2 inhibitors for the treatment of constipation
10/30/2002	EP1061957B1 Manganese (ii) chelates with high relaxivity in serum
10/30/2002	EP0854863B1 Esters and amides as pla2 inhibitors
10/30/2002	CN1377342A Processes for the preparation of tricyclic amino alcohol derivatives
10/30/2002	CN1377337A Process for phenylacetic acid derivatives
10/30/2002	CN1377336A Carboxylic acid derivatives and drugs containing the same
10/30/2002	CN1377268A Cell adhesion inhibitors
10/30/2002	CN1377259A ACE-2 inhibiting compounds and methods of use thereof
10/29/2002	US6472545 For therapy of diabetes, obesity
10/29/2002	US6472421 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an HMG CoA reductase inhibitor
10/29/2002	US6472419 1-H-3-aryl-pyrrolidine-2, 4-dione derivatives as pest-control agents
10/29/2002	US6472418 Non-peptide NK1 receptors antagonists
10/29/2002	US6472407 α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/29/2002	US6472349 Pyridine-2,3-dicarboxylic acid diamides
10/29/2002	CA2342471C Heterocyclecarbonylmethyl amine intermediates
10/28/2002	WO2001082909A2 2-acyl indol derivatives and their use as anti-tumour agents
10/28/2002	CA2407677A1 2-acyl indol derivatives and their use as anti-tumour agents
10/25/2002	WO2001083451A1 Novel bicyclic compounds
10/24/2002	WO2002083640A1 Nicotinic acetylcholine receptor ligands
10/24/2002	WO2002083639A1 Process for nitrating photocleavable compounds
10/24/2002	WO2002083622A2 Novel aminophenyl ketone derivatives
10/24/2002	WO2002083133A1 Novel oral general anesthetics and metabolitically resistant anticonvulsants
10/24/2002	WO2002083126A1 Phenylindoles for the treatment of hiv
10/24/2002	WO2002000650A3 Novel compounds possessing antibacterial, antifungal or antitumor activity
10/24/2002	US20020156295 Coordination catalyst containing ligand
10/24/2002	US20020156292 Anticancer agents
10/24/2002	US20020156276 Nitrogen-containing heterocyclic compounds and therapeutic agents for hyperlipidemia comprising the same
10/24/2002	US20020156122 Statins (HMG-CoA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
10/24/2002	US20020156120 Analgesics for migraines
10/24/2002	US20020156117 Receptor-avid exogenous optical contrast and therapeutic agents
10/24/2002	US20020156116 Antiproliferative agents for disorders with GRB-2 adaptor protein function; treating diabetes, insulin resistance, insulin deficiency and insulin allergy
10/24/2002	US20020156090 Estrogen agonist/antagonist to prevente myocardial infarction or stroke, maintaining or improving vascular reactivity, treat renal failure, peripheral arterial occlusive disease, coronary artery disease, or raynaud's phenomenon
10/24/2002	US20020156085 1,4-Disubstituted piperazine derivatives useful as uro-selective alpha1-adrenoceptor blockers
10/24/2002	US20020156083 3-hetero-arylidene-2-indolinone compounds; anticancer agents
10/24/2002	US20020156075 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents

1 ... 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 ... 458